Literature DB >> 19813042

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.

H Taggart, J Cheng, P Archbold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19813042     DOI： 10.1007/s00198-009-1088-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

1.  Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

Authors:  H M Taggart; J M Alderdice
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

2.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245
  2 in total
  1 in total

1.  Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.

Authors:  Yiyuan Zhang; Eryou Feng; Yang Xu; Wulian Wang; Tao Zhang; Lili Xiao; Rong Chen; Yu Lin; Dongdong Chen; Liqiong Lin; Kangyao Chen; Yanbin Lin
Journal:  Int J Clin Exp Med       Date:  2015-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.